News on Hantavirus_Pulmonary_Syndrome from BioPortfolio.com http://www.BioPortfolio.com Consolidated Hantavirus_Pulmonary_Syndrome news from BioPortfolio.com Wed, 10 Feb 2010 15:00:03 GMT en Lung Rx LLC, A Subsidiary Of United Therapeutics Corporation, And mondoBIOTECH holding AG Announce Today a Glohttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4010033&HITNO=0&MSIZE=26&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hantavirus_Pulmonary_Syndrome&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4010033&THISHREF=http://c.moreover.com/click/here.pl%3fz2522203900%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4010033&HITNO=0&MSIZE=26&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hantavirus_Pulmonary_Syndrome&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4010033&THISHREF=http://c.moreover.com/click/here.pl%3fz2522203900%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmacy Choice: Determinants of Postexercise Heart Rate Recovery in Patients With the Obstructive Sleep Apnea Syndromehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4013942&HITNO=1&MSIZE=26&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hantavirus_Pulmonary_Syndrome&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4013942&THISHREF=http://c.moreover.com/click/here.pl%3fz2523857118%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4013942&HITNO=1&MSIZE=26&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hantavirus_Pulmonary_Syndrome&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4013942&THISHREF=http://c.moreover.com/click/here.pl%3fz2523857118%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comCHEST: Lung Rx LLC, A Subsidiary Of United Therapeutics Corporation, And mondoBIOTECH holding AG Announce Today a Global Strategic Partnership Agreement forhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4008880&HITNO=2&MSIZE=26&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hantavirus_Pulmonary_Syndrome&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4008880&THISHREF=http://c.moreover.com/click/here.pl%3fz2521741082%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4008880&HITNO=2&MSIZE=26&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hantavirus_Pulmonary_Syndrome&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4008880&THISHREF=http://c.moreover.com/click/here.pl%3fz2521741082%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comYahoo! Canada: Lung Rx LLC, A Subsidiary Of United Therapeutics Corporation, And mondoBIOTECH holding AG Announce Today a Glohttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4007778&HITNO=3&MSIZE=26&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hantavirus_Pulmonary_Syndrome&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4007778&THISHREF=http://c.moreover.com/click/here.pl%3fz2521280971%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4007778&HITNO=3&MSIZE=26&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hantavirus_Pulmonary_Syndrome&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4007778&THISHREF=http://c.moreover.com/click/here.pl%3fz2521280971%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comGenetic Engineering News: Hantavirus Pulmonary Syndrome in Five Pediatric Patients -- Four States, 2009http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3961546&HITNO=4&MSIZE=26&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hantavirus_Pulmonary_Syndrome&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3961546&THISHREF=http://c.moreover.com/click/here.pl%3fz2496829848%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3961546&HITNO=4&MSIZE=26&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hantavirus_Pulmonary_Syndrome&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3961546&THISHREF=http://c.moreover.com/click/here.pl%3fz2496829848%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comGeneral Medicine eJournal: Hantavirus Pulmonary Syndrome in Five Pediatric Patients -- Four States, 2009http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3961435&HITNO=5&MSIZE=26&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hantavirus_Pulmonary_Syndrome&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3961435&THISHREF=http://c.moreover.com/click/here.pl%3fz2496769293%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3961435&HITNO=5&MSIZE=26&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hantavirus_Pulmonary_Syndrome&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3961435&THISHREF=http://c.moreover.com/click/here.pl%3fz2496769293%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMedscape: Aeolus Pharmaceuticals, Inc. - Aeolus Pharmaceuticals Invited to Submit Full Proposal to BARDA for AEOL 10150http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3964677&HITNO=6&MSIZE=26&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hantavirus_Pulmonary_Syndrome&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3964677&THISHREF=http://c.moreover.com/click/here.pl%3fz2498220867%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3964677&HITNO=6&MSIZE=26&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hantavirus_Pulmonary_Syndrome&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3964677&THISHREF=http://c.moreover.com/click/here.pl%3fz2498220867%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNewsRX: Aeolus Pharmaceuticals Invited to Submit Full Proposal to BARDA for AEOL 10150 as a Potential Medical Countermhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3910254&HITNO=7&MSIZE=26&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hantavirus_Pulmonary_Syndrome&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3910254&THISHREF=http://c.moreover.com/click/here.pl%3fz2468831393%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3910254&HITNO=7&MSIZE=26&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hantavirus_Pulmonary_Syndrome&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3910254&THISHREF=http://c.moreover.com/click/here.pl%3fz2468831393%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: Aeolus Pharmaceuticals Invited to Submit Full Proposal to BARDA for AEOL 10150 as a Potential Medical Countermeasure for Pulmonary Injury Associated with Acute Radiation Syndrome and Delayed Effects of Acute Radiation Exposurehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3898406&HITNO=8&MSIZE=26&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hantavirus_Pulmonary_Syndrome&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3898406&THISHREF=http://c.moreover.com/click/here.pl%3fz2462787873%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3898406&HITNO=8&MSIZE=26&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hantavirus_Pulmonary_Syndrome&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3898406&THISHREF=http://c.moreover.com/click/here.pl%3fz2462787873%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comSmartBrief: Aeolus Pharmaceuticals Invited to Submit Full Proposal to BARDA for AEOL 10150 as a Potential Medical Countermeasure for Pulmonary Injury Associated with Acute Radiation Syndrome and Delayed Effects of Acute Radiation Exposurehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3894599&HITNO=9&MSIZE=26&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hantavirus_Pulmonary_Syndrome&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3894599&THISHREF=http://c.moreover.com/click/here.pl%3fz2461056535%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3894599&HITNO=9&MSIZE=26&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hantavirus_Pulmonary_Syndrome&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3894599&THISHREF=http://c.moreover.com/click/here.pl%3fz2461056535%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFOXBusiness.com: Aeolus Pharmaceuticals Invited to Submit Full Proposal to BARDA for AEOL 10150 as a Potential Medical Countermeasure for Pulmonary Injury Associated with Acute Radiation Syndrome and Delayed Effects of Acute Radiation Exposurehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3894579&HITNO=10&MSIZE=26&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hantavirus_Pulmonary_Syndrome&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3894579&THISHREF=http://c.moreover.com/click/here.pl%3fz2461049940%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3894579&HITNO=10&MSIZE=26&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hantavirus_Pulmonary_Syndrome&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3894579&THISHREF=http://c.moreover.com/click/here.pl%3fz2461049940%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFOXBusiness.com: Aeolus Pharmaceuticals Invited to Submit Full Proposal to BARDA for AEOL 10150 as a Potential Medical Countermeasure for Pulmonary Injury Associated with Acute Radiation Syndrome and Delayed Effects of Acute Radiation Exposurehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3894572&HITNO=11&MSIZE=26&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hantavirus_Pulmonary_Syndrome&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3894572&THISHREF=http://c.moreover.com/click/here.pl%3fz2461035909%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3894572&HITNO=11&MSIZE=26&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hantavirus_Pulmonary_Syndrome&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3894572&THISHREF=http://c.moreover.com/click/here.pl%3fz2461035909%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comYour Story: Aeolus Pharmaceuticals Invited to Submit Full Proposal to BARDA for AEOL 10150 as a Potential Medical Countermeasure for Pulmonary Injury Associated with Acute Radiation Syndrome and Delayed Effects of Acute Radiation Exposurehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3894420&HITNO=12&MSIZE=26&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hantavirus_Pulmonary_Syndrome&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3894420&THISHREF=http://c.moreover.com/click/here.pl%3fz2460977937%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3894420&HITNO=12&MSIZE=26&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hantavirus_Pulmonary_Syndrome&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3894420&THISHREF=http://c.moreover.com/click/here.pl%3fz2460977937%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comCentre Daily Times: Aeolus Pharmaceuticals Invited to Submit Full Proposal to BARDA for AEOL 10150 as a Potential Medical Countermeasure for Pulmonary Injury Associated with Acute Radiation Syndrome and Delayed Effects of Acute Radiation Exposurehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3894239&HITNO=13&MSIZE=26&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hantavirus_Pulmonary_Syndrome&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3894239&THISHREF=http://c.moreover.com/click/here.pl%3fz2460948299%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3894239&HITNO=13&MSIZE=26&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hantavirus_Pulmonary_Syndrome&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3894239&THISHREF=http://c.moreover.com/click/here.pl%3fz2460948299%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBusiness Wire via Yahoo!: Aeolus Pharmaceuticals Invited to Submit Full Proposal to BARDA for AEOL 10150 as a Potential Medical Countermeasure for Pulmonary Injury Associated with Acute Radiation Syndrome and Delayed Effects of Acute Radiation Exposurehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3894112&HITNO=14&MSIZE=26&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hantavirus_Pulmonary_Syndrome&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3894112&THISHREF=http://c.moreover.com/click/here.pl%3fz2460884080%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3894112&HITNO=14&MSIZE=26&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hantavirus_Pulmonary_Syndrome&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3894112&THISHREF=http://c.moreover.com/click/here.pl%3fz2460884080%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFinanzNachrichten.de: